| Serial Number | 98592442 |
| Word Mark | OSIRIS V1 |
| Filing Date | Monday, June 10, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, April 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 29, 2025 |
| Pseudo Mark | OSIRIS V ONE |
| Goods and Services | Medical devices and apparatus, namely, medical smart glasses for medical purposes, namely, a display device for surgical navigation of Augmented Reality (AR), Virtual Reality (VR), Mixed Reality (MR), and Extended Reality (XR) systems and replacement parts and fittings therefor; Surgical apparatus and instruments for medical use; Body rehabilitation apparatus for medical purposes |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 10, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HORUSEYE TECHNOLOGY CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | New Taipei City 23144 TW |
| Event Date | Event Description |
| Monday, June 10, 2024 | NEW APPLICATION ENTERED |
| Monday, December 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 1, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 1, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 24, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 1, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, March 17, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 17, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 18, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |